Home » Stocks » PFE

Pfizer Inc. (PFE)

Stock Price: $40.80 USD 1.39 (3.51%)
Updated December 2, 3:59 PM EST - Market closed

PFE Stock Price Chart

Key Info

Market Cap 226.75B
Revenue (ttm) 48.65B
Net Income (ttm) 8.69B
Shares Out 5.56B
EPS (ttm) 1.54
PE Ratio 26.52
Forward PE n/a
Dividend $1.52
Dividend Yield 3.73%

Stock Quote

Trading Day December 2
Last Price $40.80
Previous Close $39.41
Change ($) 1.39
Change (%) 3.51%
Day's Open 40.49
Day's Range 40.30 - 41.41
Day's Volume 82,992,527
52-Week Range 27.65 - 41.41

PFE Stock News

New York Post - 47 minutes ago

European Union officials slammed the UK on Wednesday for rushing its landmark approval of Pfizer's coronavirus vaccine, saying health authorities shouldn't put speed ahead of safety. The Briti...

Other stocks mentioned: BNTX
The Motley Fool - 56 minutes ago

The healthcare leaders became the first to receive emergency authorization for their coronavirus vaccine.

Other stocks mentioned: BNTX
Market Watch - 1 hour ago

The U.K. government granted emergency use authorization to the COVID-19 vaccine being developed by Pfizer Inc. and German partner BioNTech SE with some fanfare on Wednesday, but experts cautio...

Other stocks mentioned: BNTX
Schaeffers Research - 1 hour ago

Blue-chip pharmaceutical giant Pfizer Inc. (NYSE:PFE) is making waves, as the company's coronavirus vaccine -- which was developed with BioNTech (BNTX) -- was granted emergency use approval in...

Benzinga - 2 hours ago

Pfizer Inc. (NYSE: PFE)-BioNTech SE – ADR (NASDAQ: BNTX) earned the distinction of being the first companies to receive regulatory authorization for emergency use of their investigational coro...

Other stocks mentioned: BNTX
Fox Business - 2 hours ago

United Kingdom approves Pfizer, BioNTech's COVID-19 vaccine

The United Kingdom has approved Pfizer and BioNTech's COVID-19 vaccine and plans to begin vaccinations next week, FOX Business' Edward Lawrence reports. #FoxBusiness Subscribe to Fox Business!

Other stocks mentioned: BNTX
CNBC Television - 3 hours ago

Here's what U.K. approval of Pfizer's Covid vaccine could mean for the U.S.

The U.K. on Wednesday became the first country to authorize the Pfizer-BioNTech vaccine for emergency use. The development has many hopeful the vaccine could soon be approved in the U.S. Here'...

Other stocks mentioned: BNTX
24/7 Wall Street - 4 hours ago

COVID-19 stocks were on the move on Wednesday after a few huge updates in regards to vaccine approval.

Other stocks mentioned: BNTX, MRK, MRNA
Yahoo Finance - 5 hours ago

Pfizer CEO speaks at virtual roundtable event after UK approves emergency use of coronavirus vaccine

Pfizer CEO speaks at virtual roundtable event after UK approves emergency use of coronavirus vaccine For 2020 election results please visit: Election results: https://www.yahoo.com/elections S...

Other stocks mentioned: BNTX
The Motley Fool - 5 hours ago

The vaccine will begin to be available to the public next week, says the government.

Other stocks mentioned: BNTX
Zacks Investment Research - 5 hours ago

Encouraging News on COVID-19 Vaccine

Other stocks mentioned: BNTX, MRK, MRNA
Yahoo Finance - 6 hours ago

UK approves Pfizer, BioNTech COVID-19 vaccine for use next week

The UK government has approved the BioNTech/Pfizer vaccine against COVID-19 for emergency use, becoming the first country to do so for widespread use. Yahoo Finance's Anjalee Khemlani breaks d...

Other stocks mentioned: BNTX
CNBC Television - 6 hours ago

'This is monumental'—Cramer on the U.K. approving Pfizer's Covid vaccine for general use

The U.K. on Wednesday authorized the Pfizer-BioNTech vaccine for emergency use, marking another step in the global battle against the pandemic. The vaccine will now be rolled out in the countr...

Other stocks mentioned: BNTX
Reuters - 7 hours ago

Pfizer is seeking full marketing authorisation from Britain for its COVID-19 vaccine, an executive said on Wednesday as the U.S. drugmaker gears up to deliver by the weekend the first shots fo...

Other stocks mentioned: BNTX
Business Insider - 7 hours ago

The UK became the first country in the world on Tuesday to grant emergency use authorization to Pfizer and BioNTech's COVID-19 vaccine. The vaccine, which demonstrated an efficacy rate of 95% ...

Other stocks mentioned: BNTX
Business Insider - 7 hours ago

Hi, The UK has approved Pfizer and BioNTech's coronavirus vaccine, becoming the first Western country to give a vaccine an OK. The plan is to make the vaccine available next week. 

Other stocks mentioned: BNTX
Market Watch - 8 hours ago

Care home residents and people over the age of 80 will be among the first to receive the Pfizer-BioNTech COVID-19 vaccine, when the U.K. rollout starts next week.

Other stocks mentioned: BNTX
CNET - 8 hours ago

Senior citizens will be first in line as the UK is the first country to approve Pfizer's vaccine.

Other stocks mentioned: BNTX
Market Watch - 8 hours ago

The U.K.'s regulator had been delegated much of the work to authorize Europe's medicines, and seemed better prepared than most to approve the vaccine.

Other stocks mentioned: BNTX
Business Insider - 9 hours ago

The UK has approved Pfizer and its German partner BioNTech's COVID-19 vaccine — but regulators in the US are yet to make a decision on authorization. The UK's vaccine regulator approved the sh...

Other stocks mentioned: BNTX
CNBC Television - 9 hours ago

UK approves Pfizer-BioNTech coronavirus vaccine to begin rolling out next week

The U.K. on Wednesday authorized the Pfizer-BioNTech vaccine for emergency use, marking another step in the global battle against the pandemic. The vaccine will now be rolled out in the countr...

Other stocks mentioned: BNTX
Barrons - 10 hours ago

The U.K. has become the first country to approve the Pfizer-BioNTech Covid-19 vaccine, with preparations under way to begin the rollout next week.

Other stocks mentioned: BNTX
The Motley Fool - 10 hours ago

Here's what you need to know about all of the leaders in the coronavirus vaccine race.

Other stocks mentioned: AZN, BNTX, CVAC, JNJ, MRNA, NVAX
Forbes - 11 hours ago

The vaccine will be available across the U.K. starting next week with the elderly and frontline healthcare workers being the first to receive a shot.

Other stocks mentioned: BNTX
Market Watch - 11 hours ago

U.K. becomes first country to approve a coronavirus vaccine, with immunisations to start within days for those most at risk

Other stocks mentioned: BNTX
Skynews - 11 hours ago

This is an historic moment. The beginning of the end of the pandemic.

Other stocks mentioned: BNTX
TechCrunch - 12 hours ago

The UK's medicines regulator has approved the BioNTech/Pfizer vaccine against COVID-19 for emergency use, the companies said today. The UK is the first country to approve the vaccine for wides...

Other stocks mentioned: BNTX
Bloomberg Markets and Finance - 12 hours ago

U.K. Clears Pfizer-BioNTech Covid-19 Vaccine

Dec.02 -- The U.K. became the first western country to approve a Covid-19 vaccine, with its regulator clearing Pfizer Inc. and BioNTech SE's shot ahead of decisions in the U.S. and European Un...

Other stocks mentioned: BNTX
Benzinga - 13 hours ago

Pfizer Inc (NYSE: PFE) and its German partner BioNTech SE (NASDAQ: BNTX) said Wednesday they have received regulatory approval in the United Kingdom for their COVID-19 vaccine. What Happened: ...

Other stocks mentioned: BNTX
CNBC - 14 hours ago

The U.K. has authorized the Pfizer/BioNtech coronavirus vaccine, making it the first country in the world to do so.

Other stocks mentioned: BNTX
Business Wire - 14 hours ago

NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the Medicines & Healthcare Products Regulatory Agency (MHRA) in the U.K....

Other stocks mentioned: BNTX
Skynews - 14 hours ago

The UK's independent healthcare regulator has approved use of the Pfizer/BioNtech COVID-19 vaccine.

Zacks Investment Research - 23 hours ago

November was the best month ever for the Russell 2000 index

Other stocks mentioned: AZN, IJR, IWM, MRNA, VBK
InvestorPlace - 23 hours ago

Growth stocks to buy shouldn't mean pricey or risky. Here are 7 safe growth stocks that look set for a great 2021.

Other stocks mentioned: ERIC, FOXA, GE, LYFT, RGR, BABA
Benzinga - 1 day ago

The European Medicines Agency said Tuesday it has received conditional marketing approval applications from Pfizer Inc. (NYSE: PFE)-BioNTech SE – ADR (NASDAQ: BNTX) and Moderna Inc (NASDAQ: MR...

Other stocks mentioned: BNTX, MRNA
Business Insider - 1 day ago

The COVID-19 vaccine has taken flight en route to the US.  Pfizer has tasked United Airlines with transporting the first doses of its vaccine to the US, the Wall Street Journal reported on Fri...

Other stocks mentioned: BNTX, UAL
InvestorPlace - 1 day ago

In the third quarter, Berkshire Hathaway made a number of changes. Here are seven Warren Buffett stocks that ought to be on your radar.

Other stocks mentioned: GM, KR, SNOW, COST, GOLD, WFC
Seeking Alpha - 1 day ago

Berkshire's latest filing revealed the Oracle of Omaha and his team opening new positions in four pharma giants as of late. From a quality standpoint, all companies seem like a natural fit con...

Other stocks mentioned: ABBV, BMY, MRK
Forbes - 1 day ago

Moderna and Pfizer applied to the EU's vaccine regulator this week.

Other stocks mentioned: BNTX, MRNA
The Motley Fool - 1 day ago

Should you buy these drugmaker stocks for their juicy dividend yields?

Other stocks mentioned: ABBV, GILD
Zacks Investment Research - 1 day ago

Shares of Moderna, Inc. (MRNA), Pfizer, Inc. (PFE) and AstraZeneca plc (AZN) are poised for substantial gains on encouraging final-stage trial results.

Other stocks mentioned: AZN, BNTX, GILD, LLY, MRNA
Seeking Alpha - 1 day ago

Allogeneic cell therapies have a significant cost, convenience and efficiency advantage over autologous. Data from three of the leaders: Allogene, Atara and CRISPR are expected in the next 12-...

Other stocks mentioned: ALLO, ATRA, BMY, CLLS, CRSP, GILD, NVS
New York Post - 1 day ago

Pfizer and BioNTech have asked European regulators for conditional approval of their experimental coronavirus vaccine — and officials say they could make a decision by the end of the month. Th...

Other stocks mentioned: BNTX
Business Insider - 1 day ago

Pfizer and its German partner BioNTech said Tuesday they have asked the European Union to approve their COVID-19 vaccine, but that distribution is unlikely to start until January. After submit...

Other stocks mentioned: BNTX
Market Watch - 1 day ago

Shares of Pfizer Inc. rallied 2.8% while Germany-based BioNTech SE dropped 2.5% in premarket trading Tuesday, after the company said they submitted their COVID-19 vaccine candidate BNT162b2 fo...

Other stocks mentioned: BNTX
Reuters - 1 day ago

Pfizer Inc and BioNTech have applied to the European drugs regulator for conditional authorization of their COVID-19 vaccine, following similar steps in the United States and Britain, the comp...

Other stocks mentioned: BNTX
The Motley Fool - 1 day ago

Here's what it means -- and doesn't mean.

Other stocks mentioned: BNTX, UAL
CNBC - 1 day ago

Pfizer and BioNTech said they have applied to the European Medicines Agency for the conditional marketing authorization of their coronavirus vaccine.

Other stocks mentioned: BNTX
Seeking Alpha - 2 days ago

Pfizer has been working on New Pfizer for almost a decade. The spin offs of Consumer Health and Upjohn appear to be the last steps. Continuation of the policy of dividend growth is a stated pr...

Seeking Alpha - 2 days ago

Top five holdings add up to 50% of my portfolio. Portfolio currently yields approximately 3.91%.

Other stocks mentioned: ABBV, ADSK, CSCO, D, DUK, HD, PPL, PRU, SO, T, UNMA, UPS

About PFE

Pfizer develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Sutent, Xtandi, Xalkori, Inlyta, Braftovi + Mektovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Vfend, and Zithromax brands. The company also provides medicines and vaccines in vari... [Read more...]

Industry
Drug Manufacturers-General
Founded
1849
CEO
Albert Bourla
Employees
88,300
Stock Exchange
NYSE
Ticker Symbol
PFE
Full Company Profile

Financial Performance

In 2019, Pfizer's revenue was $51.75 billion, a decrease of -3.54% compared to the previous year's $53.65 billion. Earnings were $16.27 billion, an increase of 45.91%.

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for Pfizer is 41.78, which is an increase of 2.41% from the latest price.

Price Target
$41.78
(2.41% upside)